- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 1 Diabetes Mellitus in Canada
Total 1356 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
University of British ColumbiaActive, not recruitingHyperglycemia | Diabetes | KetosisCanada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
University of British ColumbiaActive, not recruitingDiabetes Mellitus | LipohypertrophyCanada
-
Marie-France LangloisThe Lawson FoundationCompletedObesity | Glucose IntoleranceCanada
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, United States, Spain, Italy, Puerto Rico, Canada, Poland, Austria, Hungary, Israel, Greece, Taiwan, Argentina, Romania, Mexico, Slovakia
-
University of TorontoCompletedDiabetes, GestationalCanada
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
Cambridge Cardiac Care CentreUnknownMyocardial Infarction | Coronary Artery Disease | Diabetes Mellitus, Type 2 | Atrial Fibrillation | Congestive Heart FailureCanada
-
Duke UniversityEli Lilly and Company; Boehringer IngelheimActive, not recruitingCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Robert RosensonUniversity of Michigan; University of Toronto; AmgenCompletedType2 Diabetes | Microvascular Dysfunction | Atherosclerotic Vascular DiseaseUnited States, Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Spain, Germany, France, Austria, Italy
-
Vernalis (R&D) LtdCita NeuroPharmaceuticalsCompletedPain | Diabetic NeuropathiesUnited States, Canada
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Peru, Australia, Latvia, Costa Rica, Russian Federation, New Zealand, Colombia, Mexico, Czech Republic, Ecuador
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Belgium, Brazil, Canada, Czech Republic, Finland, Germany, Greece, Italy, Korea, Republic of, Mexico, Netherlands, Norway, Peru, Russian Federation, Slovakia, Spain, Taiwan
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 4United States, Argentina, Brazil, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
Sunnybrook Health Sciences CentreUnity Health Toronto; Institute for Clinical Evaluative SciencesCompletedCardiovascular Disease | Diabetes MellitusCanada
-
University of Alberta, Physical EducationCompleted
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Mexico, Poland, Canada, Austria, Belgium, Argentina, France, Bulgaria, Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Korea, Republic of, Peru, South Africa, India
-
Sunnybrook Health Sciences CentreInstitute for Clinical Evaluative SciencesCompletedCardiovascular Disease | Diabetes MellitusCanada
-
DeCell Technologies Inc.Canadian Institutes of Health Research (CIHR); Dalhousie University; Lakehead...Not yet recruitingDiabetes Mellitus | Diabetic Foot Ulcer | Wound; Foot | Wound of Skin | Tissue Injury | Ulcer Foot | Ulcer Healing | Non-healing WoundCanada
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Canada, France, Poland, Germany, Israel, India, Ukraine, Korea, Republic of, Malaysia, Netherlands, New Zealand, Singapore, Brazil, Austria, Denmark, Belgium
-
Unity Health TorontoUnknownGestational DiabetesCanada
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Poland, Germany, Bulgaria, Peru, Russian Federation, Mexico, Hungary, South Africa, Latvia, New Zealand, Costa Rica, India, Czechia, Romania, Lithuania, Puerto Rico, Chile
-
GlaxoSmithKlinePopulation Health Research InstituteTerminatedDiabetes Mellitus, Type 2United States, Germany, Russian Federation, Netherlands, South Africa, Sweden, Canada, Norway, United Kingdom, Latvia, Thailand, Colombia, India, Peru, Romania, Pakistan, Slovakia, Finland, Chile, Denmark, Argentina, Mexico, Czech Republic and more
-
University of TorontoCanadian Institutes of Health Research (CIHR); Diabetes Canada; Diabetes and...UnknownMyocardial Infarction | Cardiovascular Diseases | Heart Failure | Stroke | Arrhythmia | Type2 DiabetesCanada
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Chronic Kidney Diseases | Type 2 Diabetes MellitusEstonia, Belgium, Sweden, Italy, China, United States, Canada, Bulgaria, Chile, Denmark, Hungary, Latvia, Mexico, Russian Federation, Serbia, Spain, Portugal, Romania, Turkey, Poland, Lithuania, Argentina, Australia, Brazil, Czechia, France, Georg... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
AstraZenecaCompletedChronic Kidney Diseases | Type 2 Diabetes MellitusSpain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
-
University of TorontoCompletedGestational DiabetesCanada
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania